8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.54%
Revenue growth 50-75% of 3088.T's 3.97%. Martin Whitman would scrutinize if slower growth is temporary.
2.64%
Similar cost growth to 3088.T's 3.11%. Walter Schloss would investigate if industry cost pressures are temporary.
2.13%
Gross profit growth below 50% of 3088.T's 6.07%. Michael Burry would check for structural issues.
-0.40%
Margin decline while 3088.T shows 2.02% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.77%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
0.53%
Operating expenses growth less than half of 3088.T's 2.78%. David Dodd would verify sustainability.
2.29%
Similar total costs growth to 3088.T's 3.03%. Walter Schloss would investigate norms.
-4.00%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-14.45%
D&A reduction while 3088.T shows 4.25% growth. Joel Greenblatt would examine efficiency.
9.17%
EBITDA growth below 50% of 3088.T's 21.32%. Michael Burry would check for structural issues.
6.47%
EBITDA margin growth below 50% of 3088.T's 16.68%. Michael Burry would check for structural issues.
8.13%
Operating income growth below 50% of 3088.T's 22.98%. Michael Burry would check for structural issues.
5.45%
Operating margin growth below 50% of 3088.T's 18.28%. Michael Burry would check for structural issues.
-46.16%
Other expenses reduction while 3088.T shows 488.98% growth. Joel Greenblatt would examine advantage.
-4.06%
Pre-tax income decline while 3088.T shows 33.53% growth. Joel Greenblatt would examine position.
-6.43%
Pre-tax margin decline while 3088.T shows 28.43% growth. Joel Greenblatt would examine position.
-3.79%
Tax expense reduction while 3088.T shows 30.78% growth. Joel Greenblatt would examine advantage.
-4.25%
Net income decline while 3088.T shows 34.91% growth. Joel Greenblatt would examine position.
-6.62%
Net margin decline while 3088.T shows 29.75% growth. Joel Greenblatt would examine position.
-4.26%
EPS decline while 3088.T shows 36.73% growth. Joel Greenblatt would examine position.
-4.26%
Diluted EPS decline while 3088.T shows 36.73% growth. Joel Greenblatt would examine position.
-0.00%
Share count reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.
-0.00%
Diluted share reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.